BioNTech Fills the Gap of Approved Vaccines

Frankfurt Main, Jan 1 (AFP/APP): German firm BioNTech said Friday it was racing to ramp up production of its Covid-19 jab in Europe, to fill the “gap” left by the lack of other approved vaccines. The vaccine developed by BioNTech and its US partner Pfizer was the first to be approved in the European Union … Continue reading BioNTech Fills the Gap of Approved Vaccines